Biohit Oyj
Develops diagnostic products for early disease detection, focusing on gastroenterology.
BIOBV | HE
Overview
Corporate Details
- ISIN(s):
- FI0009005482
- LEI:
- 74370089ATTSNBXJVT29
- Country:
- Finland
- Address:
- LAIPPATIE 1, FI-00880 HELSINKI
- Sector:
- Manufacturing
Description
Biohit Oyj is a global biotechnology company that develops, manufactures, and markets innovative diagnostic products and services. The company specializes in tools for the early diagnosis and prevention of diseases, with a primary focus on gastroenterology. Its key offerings include the GastroPanel® blood test for assessing stomach health and screening for risks of gastric cancer, as well as diagnostic tests for conditions such as Helicobacter pylori infection. Operating under the mission "Innovating for Health," Biohit's products are designed to support medical research, facilitate early and accurate diagnosis, and improve patient quality of life.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2014-08-29 12:00 |
Changes to Biohit Oyj’s management
|
English | HTML • 1.6 KB | ||
| 2014-08-21 07:30 |
BIOHIT GROUP INTERIM REPORT Q2/2014
|
Finnish | HTML • 42.3 KB | ||
| 2014-08-21 07:30 |
BIOHIT GROUP INTERIM REPORT Q2/2014
|
English | HTML • 44.0 KB | ||
| 2014-08-15 07:30 |
Biohit Oyj and Eastar Pharmaceuticals LLC to sign an Acetium® lozenge distribut…
|
Finnish | HTML • 2.9 KB | ||
| 2014-08-15 07:30 |
Biohit Oyj and Eastar Pharmaceuticals LLC to sign an Acetium® lozenge distribut…
|
English | HTML • 2.8 KB | ||
| 2014-08-05 07:00 |
Chinese Health Associations give consensus clause on early gastric cancer scree…
|
Finnish | PDF • 345.9 KB | ||
| 2014-08-05 07:00 |
Chinese Health Associations give consensus clause on early gastric cancer scree…
|
English | PDF • 497.2 KB | ||
| 2014-07-01 16:00 |
Biohit Oyj and Giraffes Pharmaceutical Co. to sign an Acetium distribution agre…
|
Finnish | PDF • 307.3 KB | ||
| 2014-07-01 16:00 |
Biohit Oyj and Giraffes Pharmaceutical Co. to sign an Acetium distribution agre…
|
English | PDF • 459.8 KB | ||
| 2014-06-12 09:40 |
Biohit Oyj:n B-osakkeiden merkintä optio-oikeuksilla I ja II 2013
|
Finnish | HTML • 2.5 KB | ||
| 2014-06-12 09:40 |
Biohit Oyj B-shares Subscribed with Stock Options I and II 2013
|
English | HTML • 2.5 KB | ||
| 2014-06-11 15:00 |
The European Commission’s response to the question of food acetaldehyde by MEP …
|
Finnish | PDF • 185.3 KB | ||
| 2014-06-11 15:00 |
The European Commission’s response to the question of food acetaldehyde by MEP …
|
English | PDF • 262.1 KB | ||
| 2014-05-08 08:30 |
BIOHIT-KONSERNIN OSAVUOSIKATSAUS Q1/2014
|
Finnish | HTML • 47.9 KB | ||
| 2014-05-08 08:30 |
BIOHIT GROUP INTERIM REPORT Q1/2014
|
English | HTML • 50.1 KB |
Automate Your Workflow. Get a real-time feed of all Biohit Oyj filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Biohit Oyj
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Biohit Oyj via our API.
Peer Companies
